Cancer is now the top cause of death in the US, with key epigenetic traits providing new avenues for diagnosis and treatment.

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target CD20-expressing malignant B cells Interim safety and ...

Alicia Zhou, PhD, became CRI’s president effective August 26, and succeeded Jill O’Donnell-Tormey, PhD, who had led the Institute since 1993.

The Blumberg Institute, a nonprofit biotechnology research and education organization focused on finding a cure for hepatitis ...

Favorable safety profile seen for relapsed/refractory large B-cell lymphoma patients monitored as outpatients or inpatients.

A Watertown biotech says is received a $112 million investment led by the investment firm that manages the assets of the Novo ...

ADRX-0405 is a novel antibody-drug conjugate targeting STEAP1, and a phase 1a/b study will investigate the agent for the ...

Breast cancer is the number one cancer among women: more than 2 million cases were diagnosed worldwide in 2022. It is also ...

In a report released today, Peter Lawson from Barclays assigned a Buy rating to Nurix Therapeutics (NRIX – Research Report), with a price ...

Scottish Government official Andrew Slorance, 49, died in December 2020 at the Queen Elizabeth University Hospital in Glasgow ...

Lymphoma, a cancer of the immune system, is silently ravaging the health of Black men across America. This insidious disease, ...

Breast cancer is a major global health issue, with 2.3 million new cases in 2022. In The Bahamas, the situation is particularly alarming, as 300 to 500 women are diagnosed ...